COVID-19 and the COVID-19 Vaccine in Japan—A Review from a General Physician’s Perspective
More than 3 years have passed since the emergence of COVID-19. On 8 May 2023, COVID-19 in Japan was downgraded to Category 5 by the Infectious Disease Control Law. In Japan, at the beginning of the COVID-19 pandemic in 2020, cases of infection and deaths from severe disease were few compared with th...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-06-01
|
| Series: | Pharmacoepidemiology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2813-0618/2/3/17 |
| _version_ | 1827724405394898944 |
|---|---|
| author | Hiroshi Kusunoki |
| author_facet | Hiroshi Kusunoki |
| author_sort | Hiroshi Kusunoki |
| collection | DOAJ |
| description | More than 3 years have passed since the emergence of COVID-19. On 8 May 2023, COVID-19 in Japan was downgraded to Category 5 by the Infectious Disease Control Law. In Japan, at the beginning of the COVID-19 pandemic in 2020, cases of infection and deaths from severe disease were few compared with those in Western countries. However, in the medical field, screening for COVID-19 was given top priority, resulting in confusion and proving disadvantageous for many patients. The overreaction to COVID-19 as the most important issue in society can be attributed largely to statements by infectious disease experts. In addition, the mRNA vaccine emerged in 2021, and most of the population was vaccinated up to two times within a short period of less than 1 year because infectious disease experts strongly promoted vaccination. After 2022, when vaccination progressed and the Omicron strain, which is an attenuated strain, became the mainstay of SARS-CoV-2, the number of severe cases of COVID-19 decreased significantly; however, the number of infected people increased dramatically instead. A significant portion of the population is thought to have hybrid immunity due to vaccination plus natural infection and maintains high antibody titer levels. Henceforth, additional vaccination should be given preferentially to those who will benefit most from it. Conversely, measures against COVID-19 caused serious damage to the economy and society. Policies that not only address countermeasures against infection, but also those that encompass the economy and society as a whole, are necessary. |
| first_indexed | 2024-03-10T22:15:21Z |
| format | Article |
| id | doaj.art-6067531d3fa148e9800b945f643188e9 |
| institution | Directory Open Access Journal |
| issn | 2813-0618 |
| language | English |
| last_indexed | 2024-03-10T22:15:21Z |
| publishDate | 2023-06-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmacoepidemiology |
| spelling | doaj.art-6067531d3fa148e9800b945f643188e92023-11-19T12:28:48ZengMDPI AGPharmacoepidemiology2813-06182023-06-012318820810.3390/pharma2030017COVID-19 and the COVID-19 Vaccine in Japan—A Review from a General Physician’s PerspectiveHiroshi Kusunoki0Department of Internal Medicine, Osaka Dental University, Hirakata 573-1121, JapanMore than 3 years have passed since the emergence of COVID-19. On 8 May 2023, COVID-19 in Japan was downgraded to Category 5 by the Infectious Disease Control Law. In Japan, at the beginning of the COVID-19 pandemic in 2020, cases of infection and deaths from severe disease were few compared with those in Western countries. However, in the medical field, screening for COVID-19 was given top priority, resulting in confusion and proving disadvantageous for many patients. The overreaction to COVID-19 as the most important issue in society can be attributed largely to statements by infectious disease experts. In addition, the mRNA vaccine emerged in 2021, and most of the population was vaccinated up to two times within a short period of less than 1 year because infectious disease experts strongly promoted vaccination. After 2022, when vaccination progressed and the Omicron strain, which is an attenuated strain, became the mainstay of SARS-CoV-2, the number of severe cases of COVID-19 decreased significantly; however, the number of infected people increased dramatically instead. A significant portion of the population is thought to have hybrid immunity due to vaccination plus natural infection and maintains high antibody titer levels. Henceforth, additional vaccination should be given preferentially to those who will benefit most from it. Conversely, measures against COVID-19 caused serious damage to the economy and society. Policies that not only address countermeasures against infection, but also those that encompass the economy and society as a whole, are necessary.https://www.mdpi.com/2813-0618/2/3/17COVID-19SARS-CoV-2vaccinesbreakthrough infectionSARS-CoV-2 antibody |
| spellingShingle | Hiroshi Kusunoki COVID-19 and the COVID-19 Vaccine in Japan—A Review from a General Physician’s Perspective Pharmacoepidemiology COVID-19 SARS-CoV-2 vaccines breakthrough infection SARS-CoV-2 antibody |
| title | COVID-19 and the COVID-19 Vaccine in Japan—A Review from a General Physician’s Perspective |
| title_full | COVID-19 and the COVID-19 Vaccine in Japan—A Review from a General Physician’s Perspective |
| title_fullStr | COVID-19 and the COVID-19 Vaccine in Japan—A Review from a General Physician’s Perspective |
| title_full_unstemmed | COVID-19 and the COVID-19 Vaccine in Japan—A Review from a General Physician’s Perspective |
| title_short | COVID-19 and the COVID-19 Vaccine in Japan—A Review from a General Physician’s Perspective |
| title_sort | covid 19 and the covid 19 vaccine in japan a review from a general physician s perspective |
| topic | COVID-19 SARS-CoV-2 vaccines breakthrough infection SARS-CoV-2 antibody |
| url | https://www.mdpi.com/2813-0618/2/3/17 |
| work_keys_str_mv | AT hiroshikusunoki covid19andthecovid19vaccineinjapanareviewfromageneralphysiciansperspective |